A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia: A leukemia-lymphoma group trial of the EORTC
β Scribed by M. Hayat; U. Jehn; R. Willemze; C. Haanen; R. Zittoun; M. Monconduit; B. Lowenberg; P. Stryckmans; M. Peetermans; F. De Cataldo; H. Kerkhofs; J. Abels; H. O. Klein; J. Andrien; R. Goudsmit; C. Cauchie; S. Suciu; G. Solbu
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 624 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND: Anemia is an expected consequence of intensive chemotherapy regimens administered to patients with acute leukemia. This study was designed to determine whether epoetin alpha would decrease the number of transfusion events and units of packed erythrocytes (PRBCs) transfus
The most effective schedule of cytosine arabinoside (Ara-C) administration remains controversial and is further confused by the use of combination chemotherapy. Two remission induction regimens comprising adriamycin, Ara-C, and 6-thioguanine have been compared in patients with acute myelogenous leuk